Skip Navigation

Visiting Dana-Farber? See our prescreening and mask requirements.

Filter Results

1415 News Releases Found

_
News Releases
9/28/2023

Study offers way to increase immune checkpoint inhibitor effectiveness in patients with MTAP-deleted cancers

  • Research
  • Melanoma
  • Bladder Cancer
Jennifer Chan, MD, MPH
News Releases
9/27/2023

Study provides new look at why rare cancer often evades treatments

  • Neuroendocrine/Carcinoid Tumors
Eli Van Allen, MD
News Releases
9/19/2023

Deep learning reveals valuable clues about kidney cancer in pathology slides

  • Kidney Cancer
Rifaquat Rahman, MD
News Releases
9/18/2023

Dana-Farber Leads Adaptive, Efficient Multi-arm Phase 2 Clinical Trial for Glioblastoma

  • Glioblastoma
Laurie H. Glimcher, MD
News Releases
9/14/2023

Dana-Farber Cancer Institute and Beth Israel Deaconess Medical Center Forge New Collaboration to Advance Future of Adult Cancer Care

Pasi Jänne, MD, PhD
News Releases
9/11/2023

Dana-Farber Study Finds Up-front Chemotherapy Boost Could Benefit Patients with Non-Small Cell Lung Cancer

  • Research
  • Lung Cancer, non-small cell
Colorectal cancer cells
News Releases
9/6/2023

Study finds association between being breastfed as an infant and risk of colorectal cancer as an adult

  • Research
  • Rectal Cancer
  • Colon Cancer
Paul Richardson, MD
News Releases
8/30/2023

Potent Oral Agent Acting as Immunotherapy and Targeted Treatment Produces High Response Rate in Certain Patients

  • Research
  • Immunotherapy
  • Multiple Myeloma
Julien Dilly, MS (pictured left), and  William Freed-Pastor, MD, PhD (pictured right), recipients of PanCAN research grants
News Releases
8/30/2023

Pancreatic cancer research in vaccines, immune-based therapies and KRAS inhibition funded by The Pancreatic Cancer Action Network

  • Research
  • Pancreatic Cancer